Royal Bank Of Canada Forecasts Strong Price Appreciation for Omega Healthcare Investors (NYSE:OHI) Stock

Omega Healthcare Investors (NYSE:OHI) had its price target raised by analysts at Royal Bank Of Canada from $41.00 to $44.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “sector perform” rating on the real estate investment trust’s stock. Royal Bank Of Canada’s price objective indicates a potential upside of 1.06% from the company’s current price.

A number of other analysts have also recently commented on OHI. Wells Fargo & Company upped their price target on Omega Healthcare Investors from $44.00 to $45.00 and gave the company an “overweight” rating in a research note on Tuesday, October 21st. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Omega Healthcare Investors in a research note on Wednesday, October 8th. Truist Financial boosted their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a research note on Wednesday, September 3rd. Mizuho raised their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a research report on Thursday, September 11th. Finally, Raymond James Financial reiterated an “outperform” rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Five equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $44.29.

Omega Healthcare Investors Stock Performance

NYSE:OHI opened at $43.54 on Thursday. The firm has a market capitalization of $12.87 billion, a PE ratio of 26.88, a price-to-earnings-growth ratio of 1.85 and a beta of 0.69. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors has a 12-month low of $35.04 and a 12-month high of $43.62. The firm has a 50-day moving average price of $41.52 and a 200 day moving average price of $39.27.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.77 by $0.02. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company had revenue of $260.74 million for the quarter, compared to the consensus estimate of $262.48 million. The company’s quarterly revenue was up 14.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. Research analysts anticipate that Omega Healthcare Investors will post 2.86 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO C Taylor Pickett purchased 20,000 shares of Omega Healthcare Investors stock in a transaction on Wednesday, November 5th. The stock was purchased at an average price of $43.14 per share, with a total value of $862,800.00. Following the transaction, the chief executive officer directly owned 20,000 shares in the company, valued at $862,800. The trade was a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CIO Vikas Gupta acquired 11,500 shares of the stock in a transaction dated Thursday, November 6th. The stock was acquired at an average price of $42.97 per share, for a total transaction of $494,155.00. Following the completion of the acquisition, the executive directly owned 13,773 shares of the company’s stock, valued at $591,825.81. The trade was a 505.94% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd bought a new position in shares of Omega Healthcare Investors in the second quarter valued at about $26,000. Salem Investment Counselors Inc. acquired a new position in Omega Healthcare Investors in the 3rd quarter valued at about $39,000. Smartleaf Asset Management LLC raised its holdings in Omega Healthcare Investors by 40.9% in the 2nd quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after acquiring an additional 268 shares during the period. CENTRAL TRUST Co raised its holdings in Omega Healthcare Investors by 1,654.4% in the 2nd quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust’s stock valued at $37,000 after acquiring an additional 943 shares during the period. Finally, True Wealth Design LLC lifted its position in Omega Healthcare Investors by 273.5% during the third quarter. True Wealth Design LLC now owns 1,113 shares of the real estate investment trust’s stock worth $47,000 after acquiring an additional 815 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.